These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18986763)

  • 1. Enhancement of cytotoxicity of natural product drugs against multidrug resistant variant cell lines of human head and neck squamous cell carcinoma and breast carcinoma by tesmilifene.
    Ferguson PJ; Brisson AR; Koropatnick J; Vincent MD
    Cancer Lett; 2009 Feb; 274(2):279-89. PubMed ID: 18986763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells.
    Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A
    Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phospholipidosis-lnducing potential of the chemopotentiating drug, N,N-Diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine (DPPE, tesmilifene) correlates with its stimulation of phosphatidylserine synthesis and exposure on the plasma membrane in MCF-7 breast cancer cells.
    Xu FY; Queen G; Brandes L; Hatch GM
    Proc West Pharmacol Soc; 2007; 50():61-3. PubMed ID: 18605231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of multidrug resistance by synthetic and natural compounds in drug-resistant MCF-7 cell lines.
    Kars MD; Işeri OD; Gunduz U; Molnar J
    Chemotherapy; 2008; 54(3):194-200. PubMed ID: 18560226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential killing of breast tumor initiating cells by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine/tesmilifene.
    Deng T; Liu JC; Pritchard KI; Eisen A; Zacksenhaus E
    Clin Cancer Res; 2009 Jan; 15(1):119-30. PubMed ID: 19118039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N,N-diethyl-2-[4-(phenylmethyl) phenoxy] ethanamine (DPPE; tesmilifene), a chemopotentiating agent with hormetic effects on DNA synthesis in vitro, may improve survival in patients with metastatic breast cancer.
    Brandes LJ
    Hum Exp Toxicol; 2008 Feb; 27(2):143-7. PubMed ID: 18480139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutron radiation enhances cisplatin cytotoxicity independently of apoptosis in human head and neck carcinoma cells.
    Kim HE; Krug MA; Han I; Ensley J; Yoo GH; Forman JD; Kim HR
    Clin Cancer Res; 2000 Oct; 6(10):4142-7. PubMed ID: 11051268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pO2 on antitumor drug cytotoxicity on MDR and non-MDR variants selected from the LoVo metastatic colon carcinoma cell line.
    Lelong-Rebel I; Brisson C; Fabre M; Bergerat JP; Rebel G
    Anticancer Res; 2008; 28(1A):55-68. PubMed ID: 18383825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to cytotoxic chemotherapy-induced apoptosis in side population cells of human oral squamous cell carcinoma cell line Ho-1-N-1.
    Yajima T; Ochiai H; Uchiyama T; Takano N; Shibahara T; Azuma T
    Int J Oncol; 2009 Aug; 35(2):273-80. PubMed ID: 19578740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX; Yang XH
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines.
    Aissat N; Le Tourneau C; Ghoul A; Serova M; Bieche I; Lokiec F; Raymond E; Faivre S
    Cancer Chemother Pharmacol; 2008 Jul; 62(2):305-13. PubMed ID: 17912526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Head and neck cancer cell lines are resistant to mitochondrial-depolarization-induced apoptosis.
    Zhao M; Mydlarz WK; Zhou S; Califano J
    ORL J Otorhinolaryngol Relat Spec; 2008; 70(4):257-63. PubMed ID: 18483464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer.
    Labbozzetta M; Notarbartolo M; Poma P; Maurici A; Inguglia L; Marchetti P; Rizzi M; Baruchello R; Simoni D; D'Alessandro N
    Ann N Y Acad Sci; 2009 Feb; 1155():278-83. PubMed ID: 19250217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.
    Bartolini G; Orlandi M; Papi A; Ammar K; Guerra F; Ferreri AM; Rocchi P
    In Vivo; 2006; 20(6A):729-33. PubMed ID: 17203756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptotic mechanism of paclitaxel-induced cell death in human head and neck tumor cell lines.
    Hsiao JR; Leu SF; Huang BM
    J Oral Pathol Med; 2009 Feb; 38(2):188-97. PubMed ID: 19200178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head and neck squamous cell carcinoma is highly sensitive to vinorelbine in Vitro.
    Erjala K; Pulkkinen J; Kulmala J; Alanen K; Grenman R
    Anticancer Res; 2002; 22(6A):3135-42. PubMed ID: 12530056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of rational in vitro models for drug resistance in breast cancer and modulation of MDR by selected compounds.
    Kars MD; Iseri OD; Gündüz U; Ural AU; Arpaci F; Molnár J
    Anticancer Res; 2006; 26(6B):4559-68. PubMed ID: 17201178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.
    Yang C; Hornicek FJ; Wood KB; Schwab JH; Mankin H; Duan Z
    Cancer Chemother Pharmacol; 2009 Aug; 64(3):607-14. PubMed ID: 19125251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells?
    Azab SS; Salama SA; Abdel-Naim AB; Khalifa AE; El-Demerdash E; Al-Hendy A
    Breast Cancer Res Treat; 2009 Jan; 113(1):9-19. PubMed ID: 18228136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.